Search Results 1011-1020 of 16373 for pharmacogenetics
Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the ...
The primary purpose of this study is to create a prospective registry of patients with pouch-related conditions to allow for longitudinal assessment of outcomes ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic researchers have found a 32-gene signature that is a promising prognostic and predictive biomarker for patients with gastric cancer.
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Cheryl L. Willman, M.D., began her role leading Mayo Clinic Comprehensive Cancer Center in 2021. Using big data and analytics, she plans to continue ...
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
Study design. Devising observational and experimental studies. · Data collection techniques. · Translation. · Implementation science. · Research ethics. · Scientific ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.